access to justice
Medical Devices
Prescription Drugs
Vehicle Accidents
Women’s Health
Home » Archive by Category

Articles in Prescription Drugs

Long Term Use Of Fosamax and Boniva Causes Thigh Bone Fractures, Tennessee Patient Charges in Lawsuit

December 15, 2011 – 3:34 pm | Comments Off | 307 views
Long Term Use Of Fosamax and Boniva Causes Thigh Bone Fractures, Tennessee Patient Charges in Lawsuit

Reba Inez Patton of Tennessee spoke about her atypical femur fracture, which may have been caused by Fosamax and Boniva osteoprosis drugs: “When I walk, it is scary because I do not want to fall …

College Student Who Died From Prescribed Yaz Profiled by CBS Early Show

July 6, 2011 – 2:48 am | Comments Off | 97 views
College Student Who Died From Prescribed Yaz Profiled by CBS Early Show

The CBS Early Show interviewed Joan Cummins, the mother of Michelle Pfleger who died last year while walking to her morning class at college.

Fosamax Problems and Side Effect Video Update

June 9, 2011 – 10:15 am | Comments Off | 135 views
Fosamax Problems and Side Effect Video Update

Attorney Wendy Fleishman discusses alleged Fosamax side effects and litigation.

FDA Expands Safety Review of Yaz, Gianvi, Yasmin, Ocella and other Birth Control Drugs

May 31, 2011 – 3:05 pm | Comments Off | 168 views
FDA Expands Safety Review of Yaz, Gianvi, Yasmin, Ocella and other Birth Control Drugs

As part of its ongoing safety assessment of birth control pills, the Food and Drug Administration (FDA) announced on May 31, 2011, that is reviewing two newly published studies on the risk of blood clots in women who use birth control pills that contain drospirenone.

Yaz Birth Control Pill Dangers: Death of 18-year College Student Leads to Yaz Lawsuit

May 10, 2011 – 2:44 pm | Comments Off | 163 views
Yaz Birth Control Pill Dangers: Death of 18-year College Student Leads to Yaz Lawsuit

Last September, Michelle Pfleger was walking to her morning class at Elon University in North Carolina when she suddenly collapsed. Michelle was taken to a nearby hospital, but despite the efforts of the medical professionals, she died.

Fosamax and Other Osteoporosis Drugs: New Study on Risk of Thigh Bone Fractures

May 6, 2011 – 3:31 pm | Comments Off | 200 views
Fosamax and Other Osteoporosis Drugs: New Study on Risk of Thigh Bone Fractures

In a study published on May 4, 2011 in the New England Journal of Medicine, researchers found increased risk of atypical femur fractures.

Yaz, Yasmin: Medical Evidence of Greater Danger of Blood Clots Mounts

April 22, 2011 – 10:56 pm | Comments Off | 95 views
Yaz, Yasmin: Medical Evidence of Greater Danger of Blood Clots Mounts

Two new studies show that women who take birth control pills with the newer hormone drospirenone, including Bayer HealthCare Pharmaceuticals Inc.’s Yasmin and Yaz, have a three-fold higher risk of developing potentially serious blood clots than women who take oral contraceptives containing the older hormone levonorgestrel.

Long-Term Use of Osteoporosis Drugs and Increased Risk of Fractures

February 23, 2011 – 1:24 pm | Comments Off | 217 views
Long-Term Use of Osteoporosis Drugs and Increased Risk of Fractures

In February 2011, the JAMA published a study finding that long-term osteoporosis treatment with bisphosphonates increases the risk of rare femur fractures

Frequent Use of Over-the-Counter Painkillers Poses Serious Health Dangers

February 14, 2011 – 12:38 pm | Comments Off | 94 views
Frequent Use of Over-the-Counter Painkillers Poses Serious Health Dangers

The U.S. Food and Drug Administration states more than 50% of patients do not take over-the-counter medication as directed. Research confirms that overdosing on over-the-counter painkillers may lead to organ failure, strokes, and even death.

Pain Killers & Liver Failure: FDA Restricts Acetaminophen in Some Products

January 14, 2011 – 11:11 am | Comments Off | 202 views
Pain Killers & Liver Failure: FDA Restricts Acetaminophen in Some Products

The FDA is restricting the amount of acetaminophen in the nation’s most popular prescription painkillers based on the use of over-the-counter painkillers containing acetaminophen such as Tylenol, and the link between thousands of cases of liver damage.

Bayer Healthcare To Launch New Birth Control Pill Amid Controversy Over Yaz Oral Contraceptive

August 24, 2010 – 4:22 pm | Comments Off | 242 views
Bayer Healthcare To Launch New Birth Control Pill Amid Controversy Over Yaz Oral Contraceptive

Bayer to release new birth control drug called Natazia.

Diabetes Drug Avandia : Drug Maker’s Study Under Investigation

July 13, 2010 – 11:12 am | Comments Off | 84 views
Diabetes Drug Avandia : Drug Maker’s Study Under Investigation

The New York Times reported this week that GlaxoSmithKline, the maker of Avandia, a prescription drug intended for the treatment of Type 2 diabetes, undertook a secret study in 1999 that it has attempted to keep unknown for the past 11 years.

Diabetes Drug Avandia and Strokes and Heart Attacks: Further Evidence of Link

July 2, 2010 – 2:30 pm | Comments Off | 238 views
Diabetes Drug Avandia and Strokes and Heart Attacks: Further Evidence of Link

The Los Angeles Times reported that the prescription diabetes drug, Avandia, is linked with an increased risk of hearts attacks, heart failure and strokes, as released in two independent recent study findings.

Paxil, Pregnancy and Birth Defects: Litigation Update

July 2, 2010 – 1:57 pm | Comments Off | 214 views
Paxil, Pregnancy and Birth Defects: Litigation Update

Bloomberg News has reported that GlaxoSmithKline, the manufacturer of the antidepressant prescription drug Paxil, has entered into settlements with nearly 200 families for a total of $1 billion. The families charged in lawsuits that Paxil caused birth defects.

Avandia Diabetes Drug And Patient Heart Attacks Linked, New York Times Reports

February 20, 2010 – 11:51 am | Comments Off | 168 views
Avandia Diabetes Drug And Patient Heart Attacks Linked, New York Times Reports

Confidential government reports disclosed to the New York Times recommend that the diabetes drug Avandia be removed from the market because of the significant risk of heart attacks and the availability of a safer alternative drug.